硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变的临床研究

doi:10.12114/j.issn.1007-9572.2018.00.175

中国全科医学 ›› 2018, Vol. 21 ›› Issue (26): 3175-3178.DOI: 10.12114/j.issn.1007-9572.2018.00.175

硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变的临床研究

李东风1，章秋2*

1.237000安徽省六安市，皖西卫生职业学院附属医院六安市第二人民医院内分泌科　2.230022安徽省合肥市，安徽医科大学第一附属医院内分泌科
*通信作者：章秋，主任医师，教授，博士生导师；E-mail：aynfmk@163.com

出版日期:2018-09-15 发布日期:2018-09-15
基金资助:
基金项目：安徽省高校自然科学基金科研重大项目（KJ2017ZD19）

Clinical Study of Thioctic Acid Sequential Therapy Combined with Epalrestat in the Treatment of Diabetic Painful Neuropathy

LI Dong-feng1，ZHANG Qiu2*

1.Department of Endocrinology，Affiliated Hospital of Anhui Health Career/Lu'an Second People's Hospital，Lu'an 237000，China
2.Department of Endocrinology，the First Affiliated Hospital of Anhui Medical University，Hefei 230022，China
*Corresponding author：ZHANG Qiu，Chief physician，Professor，Doctoral supervisor；E-mail：aynfmk@163.com

Published:2018-09-15 Online:2018-09-15

分享到

摘要/Abstract

摘要： 目的　探讨硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变（PDN）的临床效果。方法　选取2016年六安市第二人民医院内分泌科收治的PDN患者80例为研究对象，采用随机数字表法将其分为观察组和对照组，各40例。观察组采用硫辛酸序贯疗法联合依帕司他治疗8周，对照组采用甲钴胺序贯疗法联合依帕司他治疗8周，记录两组患者治疗8周后临床疗效，治疗前及治疗8周后检测正中神经、腓总神经运动神经传导速度（MNCV）和感觉神经传导速度（SNCV）。结果　治疗后观察组显效33例（82.5%），有效6例（15.0%），无效1例（2.5%）；对照组显效9例（22.5%），有效21例（52.5%），无效10例（25.0%）；观察组临床疗效优于对照组（u=4.81，P<0.01）。治疗前，两组患者正中神经和腓总神经MNCV和SNCV比较，差异均无统计学意义（P>0.05）；治疗后，观察组患者正中神经和腓总神经MNCV和SNCV较对照组升高（P<0.05）；观察组患者正中神经和腓总神经MNCV和SNCV治疗前后差值较对照组增大（P<0.05）。两组患者均未发生严重不良反应。结论　与甲钴胺相比，采用硫辛酸序贯疗法联合依帕司他治疗PDN效果更明显，可明显提高神经传导速度，且用药安全性好。

关键词: 糖尿病神经病变, 硫辛酸, 依帕司他, 神经传导

Abstract: Objective　To investigate the clinical effects of thioctic acid sequential therapy combined with epalrestat in the treatment of diabetic painful neuropathy （PDN）.Methods　A total of 80 patients with PDN admitted to the Department of Endocrinology of Lu'an Second People's Hospital in 2016 were enrolled as the study subjects.The random number table was adopted to divide the patients into the observation group and the control group，each with 40 cases.The observation group was treated with thioctic acid sequential therapy combined with epalrestat for 8 weeks.The control group was treated with mecobalamin sequential therapy combined with epalrestat for 8 weeks.The clinical efficacy of the two groups of patients after treatment was recorded.The motor nerve conduction velocity （MNCV） and sensory nerve conduction velocity （SNCV） of median nerve and common peroneal nerve were measured before and after the treatment.Results　In the observation group，33 cases（82.5%） were markedly effective，6 cases（15.0%） improved，and 1 case（2.5%） failed.In the control group，9 cases （22.5%）were markedly effective，21 cases （52.5%）improved，and 10 cases（25.0%） failed.The clinical efficacy of the observation group was better than that of the control group （u=4.81，P<0.01）.Before the treatment，there was no significant difference in MNCV and SNCV of median and peroneal nerves between the two groups （P>0.05）.After the treatment，the MNCV and SNCV of median nerve and peroneal nerve in the observation group were higher than those in the control group （P<0.05）.The difference in MNCV and SNCV of median and peroneal nerves before and after the treatment in the observation group were higher than those in the control group （P<0.05）.No serious adverse reaction occurred in both two groups.Conclusion　Compared with mecobalamin，the use of thioctic acid sequential therapy combined with epalrestat for the treatment of PDN is more effective and safer，so it is worthy of clinical application.

Key words: Diabetic neuropathies, Thioctic acid, Epalrestat, Neural conduction

李东风,章秋. 硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变的临床研究[J]. 中国全科医学, 2018, 21(26): 3175-3178. DOI: 10.12114/j.issn.1007-9572.2018.00.175.
LI Dong-feng,ZHANG Qiu. Clinical Study of Thioctic Acid Sequential Therapy Combined with Epalrestat in the Treatment of Diabetic Painful Neuropathy[J]. Chinese General Practice, 2018, 21(26): 3175-3178. DOI: 10.12114/j.issn.1007-9572.2018.00.175.

参考文献

［1］中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）［J］.中华糖尿病杂志，2014，6（7）：447-498.DOI：10.3760/cma.j.issn.1674-5809.2014.07.004.3178
Chinese Diabetes Society.Guideline for prevention and treatment of type 2 diabetes in Chinese（2013 edition）［J］.Chinese Journal of Diabetes，2014，6（7）：447-498.DOI：10.3760/cma.j.issn.1674-5809.2014.07.004.3178
［2］JENSEN T S.New understanding of mechanisms of painful diabetic neuropathy：a path to prevention and better treatment?［J］.Scand J Pain，2017，4（3）：127-128.DOI：10.1016/j.sjpain.2013.04.004.3178
［3］BORG I，MIZZI S，FORMOSA C.Plantar pressure distribution in patients with diabetic peripheral neuropathy and a first-ray amputation［J］.J Am Podiatr Med Assoc，2018，108（3）：225-230.DOI：10.7547/16-021.3178
［4］李琴，李兴，张庙生.盐酸度洛西汀联合硫辛酸治疗糖尿病痛性神经病变的疗效分析［J］.中国医疗前沿，2013，8（8）：6-8.DOI：10.3969/j.issn.1673-5552.2013.08.0003.3178
LI Q，LI X，ZHANG M S.Analysis of curative effect of duloxetine hydrochloride in combination with thioctic acid in treatment of painful diabetic neuropathy［J］.China Healthcare Innovation，2013，8（8）：6-8.DOI：10.3969/j.issn.1673-5552.2013.08.0003.3178
［5］陈华琴，郑访江，祁琴，等.α-硫辛酸联合高压氧治疗糖尿病周围神经病变的疗效观察［J］.内科，2017，12（5）：660-662，697.DOI：10.16121/j.cnki.cn45-1347/r.2017.05.19.3178
CHEN H Q，ZHENG F J，QI Q，et al.Effect of thioctic acid combined with hyperbaric oxygen on diabetic peripheral neuropathy［J］.Internal Medicine，2017，12（5）：660-662，697.DOI：10.16121/j.cnki.cn45-1347/r.2017.05.19.3178
［6］张贺成，魏苏，李庆凤.硫辛酸联合甲钴胺治疗糖尿病周围神经病变的疗效观察［J］.安徽医学，2014，35（9）：1238-1240.DOI：10.3969/j.issn.1000-0399.2014.09.021.3178
ZHANG H C，WEI S，LI Q F.Observation of curative effect of lipoic acid in combination with a cobalt amine in treatment of diabetic peripheral neuropathy［J］.Anhui Medical Journal，2014，35（9）：1238-1240.DOI：10.3969/j.issn.1000-0399.2014.09.021.3178
［7］金雪花，付鸿玉，唐海燕，等.α-硫辛酸、甲钴胺、前列地尔联合治疗糖尿病周围神经病变58例临床观察［J］.当代医学，2011，17（3）：151-152.DOI：10.3969/j.issn.1009-4393.2011.3.105.3178
JIN X H，FU H Y，TANG H Y，et al.Clinical observation of thioctic acid，mecobalamin combined with alprostadil in treatment of diabetic peripheral neuropathy in 58 cases［J］.Contemporary Medicine，2011，17（3）：151-152.DOI：10.3969/j.issn.1009-4393.2011.3.105.3178
［8］GOMEZ-OLIVE F X，THOROGOOD M，CLARK B，et al.Self-reported health and health care use in an ageing population in the Agincourt sub-district of rural South Africa［J］.Glob Health Action，2013，6：19305.DOI：10.3402/gha.v6i0.19305.3178

[1]	卢春键, 刘薇, 林少霞, 朱燕娴, 皮敏. 五种常用中医外治法联合常规西药治疗糖尿病周围神经病变有效性和安全性的贝叶斯网状Meta分析[J]. 中国全科医学, 2022, 25(33): 4106-4116.
[2]	赵蕾, 李如强, 袁明霞. 亚临床甲状腺功能减退症对糖尿病心脏自主神经病变的影响研究[J]. 中国全科医学, 2022, 25(09): 1113-1118.
[3]	李永生, 张学良, 李丞, 封志炜, 王凯. 2型糖尿病周围神经病变风险的列线图预测模型研究[J]. 中国全科医学, 2022, 25(06): 675-681.
[4]	吴蓝雪，汪四虎，黄大祥，黄利娟，何江，章秋. 2型糖尿病并发痛性糖尿病神经病变的影响因素研究[J]. 中国全科医学, 2021, 24(6): 658-662.
[5]	奚悦，王园媛，崔秀玲. α-硫辛酸在Graves'病合并肝损伤中的保护作用及机制研究[J]. 中国全科医学, 2019, 22(8): 931-935.
[6]	杨辉1，施榕1*，朱静芬1，贾丽丽2，娄洁琼1，龙雯1，冯易1，梁辰1，张胜冰3，宋道平4，蒋玉立5，顾文娟6，彭云7，程慧琴8，秦飞1. 上海市社区2型糖尿病患者糖尿病周围神经病变现况调查[J]. 中国全科医学, 2017, 20(5): 579-585.
[7]	陈明月，蔡慧敏*，陈江云，张宁，王蕊. 密歇根糖尿病神经病变评分和多伦多临床评分系统在糖尿病周围神经病变中的诊断价值研究[J]. 中国全科医学, 2017, 20(4): 427-431.
[8]	王景尚1，孙明月2，黄烨3*，殷惠军4. α-硫辛酸对血糖波动状态下2型糖尿病大鼠血管内皮细胞功能及PI3K/Akt/GSK-3β通路的影响[J]. 中国全科医学, 2017, 20(24): 2965-2971.
[9]	程迪赫,周丽诺. 糖尿病心血管自主神经病变的非药物治疗研究进展[J]. 中国全科医学, 2016, 19(14): 1726-1728.
[10]	唐键，王博，张玄娥，程笑冰，唐文佳，顾蕾，周尊海. 2型糖尿病患者并发糖尿病周围神经病变危险因素分析[J]. 中国全科医学, 2015, 18(30): 3657-3661.
[11]	马静，李凯利，马丽. 温通活血乳膏对糖尿病周围神经病变大鼠超氧化物歧化酶及丙二醛水平影响研究[J]. 中国全科医学, 2015, 18(21): 2584-2588.

硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变的临床研究

Clinical Study of Thioctic Acid Sequential Therapy Combined with Epalrestat in the Treatment of Diabetic Painful Neuropathy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

留言